
Gujarat Terce Laboratories Ltd is Rated Sell
2026-10-30 10:10:04Gujarat Terce Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read More
Gujarat Terce Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-10-07 08:38:27Gujarat Terce Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The pharmaceutical micro-cap’s recent price surge of 9.10% to ₹38.00 reflects renewed market interest, although underlying financials remain subdued. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change on 6 October 2026.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
07-Nov-2026 | Source : BSEDetailed disclosure is attached.
Unaudited Standalone Financial Results Of The Company For The Second Quarter And Half Year Ended 30 September 2026
05-Nov-2026 | Source : BSEDetailed disclosure is attached.
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended From Time To Time (Listing Regulations)
05-Nov-2026 | Source : BSEDetailed disclosure is attached.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available